SHAREHOLDER ALERT: Investigation on Behalf of Investors of Sanofi Announced by Law Offices of Howard G. Smith

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Sanofi (the “Company”) (NYSE:SNY) concerning possible violations of federal securities laws. The investigation is focused on the Company’s operations and financial performance.

Sanofi discovers, develops and distributes therapeutic solutions, including pharmaceuticals and vaccines used by veterinarians, consumer health care products, and generic medicines. The investigation is related to allegations that Sanofi misrepresented or failed to disclose that the Company was making improper payments to healthcare professionals in connection with the sale of pharmaceutical products, in violation of federal law, and that Sanofi’s internal controls over financial reporting were inadequate.

If you purchased Sanofi shares between February 7, 2013 and December 3, 2014, if you have information or would like to learn more about these claims, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.